News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ignyta Announces First Quarter 2014 Company Highlights And Financial Results


5/12/2014 7:06:19 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, today announced company highlights and financial results for the first quarter ended March 31, 2014.

“Since the beginning of 2014, we have made solid progress in developing improved treatment options for cancer patients with our proprietary drug candidates and expanding our integrated Rx/Dx discovery and development capabilities,” said Jonathan Lim, M.D., Chairman and CEO of Ignyta.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Ignyta
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES